Phlebolymphedema: Impact of Flexitouch Therapy on Costs

Phlebolymphedema Impact of Flexitouch Therapy on CostsHighlights from an insurance-claims analysis of the impact of Flexitouch advanced pneumatic compression device (APCD) therapy on healthcare costs in venous-related lymphedema (phlebolymphedema).

Flexitouch APCD therapy plus conservative treatment reduced healthcare costs by:

  • 69% compared with conservative therapy alone.
  • 85% compared with simple pneumatic compression devices (SPCDs).
  • 53% compared with other APCDs.